| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myositis, Inclusion Body | 27 | 2026 | 57 | 7.480 |
Why?
|
| Myositis | 21 | 2025 | 106 | 4.840 |
Why?
|
| Amyotrophic Lateral Sclerosis | 16 | 2024 | 175 | 4.650 |
Why?
|
| Frontotemporal Dementia | 11 | 2023 | 65 | 4.250 |
Why?
|
| Muscle, Skeletal | 25 | 2026 | 1005 | 2.570 |
Why?
|
| Drosophila Proteins | 14 | 2025 | 786 | 1.990 |
Why?
|
| Charcot-Marie-Tooth Disease | 10 | 2023 | 237 | 1.960 |
Why?
|
| Active Transport, Cell Nucleus | 7 | 2025 | 120 | 1.890 |
Why?
|
| Neurodegenerative Diseases | 3 | 2025 | 288 | 1.840 |
Why?
|
| C9orf72 Protein | 10 | 2023 | 42 | 1.640 |
Why?
|
| Drosophila melanogaster | 11 | 2023 | 850 | 1.520 |
Why?
|
| Nuclear Pore Complex Proteins | 4 | 2025 | 26 | 1.380 |
Why?
|
| Cell Nucleus | 4 | 2025 | 569 | 1.340 |
Why?
|
| DNA-Binding Proteins | 8 | 2025 | 1972 | 1.300 |
Why?
|
| Drosophila | 15 | 2025 | 794 | 1.170 |
Why?
|
| DNA Repeat Expansion | 7 | 2023 | 38 | 1.150 |
Why?
|
| Nuclear Pore | 3 | 2025 | 18 | 1.100 |
Why?
|
| Valosin Containing Protein | 3 | 2025 | 16 | 1.050 |
Why?
|
| Autoimmune Diseases | 7 | 2023 | 264 | 1.020 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2021 | 132 | 0.960 |
Why?
|
| TRPV Cation Channels | 3 | 2021 | 46 | 0.890 |
Why?
|
| Dermatomyositis | 7 | 2023 | 35 | 0.850 |
Why?
|
| Muscular Diseases | 5 | 2023 | 124 | 0.810 |
Why?
|
| RNA Splicing | 1 | 2025 | 237 | 0.790 |
Why?
|
| Polymyositis | 5 | 2020 | 17 | 0.790 |
Why?
|
| Animals | 42 | 2025 | 33892 | 0.770 |
Why?
|
| Motor Neurons | 6 | 2021 | 136 | 0.760 |
Why?
|
| Heterografts | 2 | 2022 | 193 | 0.750 |
Why?
|
| Lysosomes | 4 | 2022 | 269 | 0.750 |
Why?
|
| Mutation | 14 | 2025 | 6131 | 0.740 |
Why?
|
| Autoantibodies | 8 | 2025 | 439 | 0.740 |
Why?
|
| Neuroimaging | 2 | 2016 | 389 | 0.680 |
Why?
|
| Autophagy | 2 | 2023 | 421 | 0.680 |
Why?
|
| Synaptic Transmission | 6 | 2018 | 320 | 0.670 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2020 | 12 | 0.670 |
Why?
|
| Neuromuscular Junction | 4 | 2014 | 92 | 0.640 |
Why?
|
| Animals, Genetically Modified | 7 | 2020 | 327 | 0.620 |
Why?
|
| Humans | 79 | 2026 | 130422 | 0.620 |
Why?
|
| Presynaptic Terminals | 4 | 2018 | 79 | 0.610 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2020 | 139 | 0.600 |
Why?
|
| Disease Models, Animal | 12 | 2025 | 4656 | 0.590 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 257 | 0.580 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 199 | 0.580 |
Why?
|
| Axonal Transport | 2 | 2022 | 27 | 0.560 |
Why?
|
| Calcium Signaling | 1 | 2020 | 242 | 0.560 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group F-H | 1 | 2018 | 3 | 0.560 |
Why?
|
| Transcription Factor TFIID | 2 | 2018 | 17 | 0.560 |
Why?
|
| Ataxin-2 | 1 | 2018 | 7 | 0.560 |
Why?
|
| RNA-Binding Protein FUS | 2 | 2018 | 20 | 0.550 |
Why?
|
| GTP Phosphohydrolases | 2 | 2020 | 158 | 0.540 |
Why?
|
| RNA | 4 | 2023 | 520 | 0.530 |
Why?
|
| Muscle Strength | 5 | 2023 | 82 | 0.530 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2024 | 101 | 0.520 |
Why?
|
| Mitochondrial Proteins | 2 | 2020 | 278 | 0.520 |
Why?
|
| Interferon-gamma | 3 | 2026 | 545 | 0.490 |
Why?
|
| Electromyography | 2 | 2016 | 139 | 0.490 |
Why?
|
| Syringomyelia | 1 | 2016 | 21 | 0.480 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 395 | 0.480 |
Why?
|
| Whole Body Imaging | 1 | 2016 | 28 | 0.480 |
Why?
|
| Polyneuropathies | 1 | 2016 | 31 | 0.480 |
Why?
|
| Flavoproteins | 1 | 2015 | 21 | 0.470 |
Why?
|
| Endosomes | 3 | 2015 | 72 | 0.470 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 291 | 0.460 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 99 | 0.450 |
Why?
|
| RNA-Binding Proteins | 3 | 2018 | 541 | 0.440 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2025 | 246 | 0.430 |
Why?
|
| Neurologic Examination | 2 | 2020 | 185 | 0.420 |
Why?
|
| Male | 38 | 2026 | 64527 | 0.420 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 258 | 0.420 |
Why?
|
| Proteins | 2 | 2016 | 1015 | 0.410 |
Why?
|
| Endocytosis | 3 | 2002 | 126 | 0.390 |
Why?
|
| Peripheral Nerves | 1 | 2013 | 91 | 0.380 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2017 | 253 | 0.360 |
Why?
|
| Female | 35 | 2026 | 70285 | 0.330 |
Why?
|
| Calcium | 4 | 2021 | 1027 | 0.310 |
Why?
|
| Vacuoles | 2 | 2022 | 30 | 0.310 |
Why?
|
| Phenotype | 11 | 2023 | 4474 | 0.300 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 346 | 0.300 |
Why?
|
| Middle Aged | 21 | 2025 | 28383 | 0.300 |
Why?
|
| Genes, Modifier | 2 | 2019 | 14 | 0.290 |
Why?
|
| Mice | 14 | 2025 | 18188 | 0.290 |
Why?
|
| Aged | 18 | 2025 | 20894 | 0.290 |
Why?
|
| Adult | 21 | 2025 | 31127 | 0.280 |
Why?
|
| Autoantigens | 2 | 2025 | 99 | 0.260 |
Why?
|
| Antibody Formation | 2 | 2025 | 227 | 0.260 |
Why?
|
| Neurons | 5 | 2018 | 2010 | 0.260 |
Why?
|
| Dendritic Cells | 2 | 2026 | 435 | 0.240 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2022 | 28 | 0.230 |
Why?
|
| Aged, 80 and over | 9 | 2025 | 6781 | 0.230 |
Why?
|
| Longitudinal Studies | 5 | 2022 | 1485 | 0.230 |
Why?
|
| HIV Infections | 1 | 2017 | 2013 | 0.220 |
Why?
|
| Transcriptome | 5 | 2024 | 1129 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2013 | 975 | 0.210 |
Why?
|
| RNA Helicases | 2 | 2023 | 75 | 0.210 |
Why?
|
| Nuclear Proteins | 3 | 2025 | 1229 | 0.200 |
Why?
|
| Motor Cortex | 2 | 2021 | 60 | 0.200 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 3 | 2020 | 32 | 0.200 |
Why?
|
| Motor Neuron Disease | 2 | 2014 | 16 | 0.200 |
Why?
|
| Mice, Inbred NOD | 2 | 2025 | 301 | 0.200 |
Why?
|
| Young Adult | 10 | 2021 | 9995 | 0.200 |
Why?
|
| Proteostasis Deficiencies | 1 | 2023 | 6 | 0.200 |
Why?
|
| Creatine Kinase | 3 | 2018 | 64 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2025 | 291 | 0.200 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2023 | 27 | 0.190 |
Why?
|
| Nerve Degeneration | 2 | 2021 | 134 | 0.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2025 | 583 | 0.190 |
Why?
|
| Regeneration | 2 | 2018 | 230 | 0.190 |
Why?
|
| Exercise Therapy | 1 | 2024 | 169 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 3815 | 0.190 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2020 | 131 | 0.190 |
Why?
|
| Muscular Dystrophy, Oculopharyngeal | 1 | 2022 | 2 | 0.190 |
Why?
|
| Biopsy | 5 | 2025 | 1239 | 0.190 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2022 | 11 | 0.190 |
Why?
|
| HeLa Cells | 2 | 2021 | 698 | 0.190 |
Why?
|
| HEK293 Cells | 3 | 2021 | 809 | 0.180 |
Why?
|
| Cortactin | 1 | 2021 | 3 | 0.180 |
Why?
|
| Peptide Library | 1 | 2022 | 56 | 0.180 |
Why?
|
| Osteonecrosis | 1 | 2022 | 17 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2021 | 5069 | 0.180 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2022 | 37 | 0.180 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2018 | 7 | 0.180 |
Why?
|
| Biomarkers | 4 | 2026 | 3394 | 0.180 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 189 | 0.180 |
Why?
|
| Myocarditis | 1 | 2023 | 132 | 0.170 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 238 | 0.170 |
Why?
|
| Pluripotent Stem Cells | 1 | 2022 | 78 | 0.170 |
Why?
|
| GTPase-Activating Proteins | 2 | 2019 | 85 | 0.170 |
Why?
|
| Muscle Weakness | 2 | 2019 | 89 | 0.170 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2002 | 150 | 0.170 |
Why?
|
| Neurites | 1 | 2021 | 44 | 0.170 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 44 | 0.170 |
Why?
|
| Trans-Activators | 2 | 2021 | 705 | 0.170 |
Why?
|
| Bacteriophages | 1 | 2022 | 97 | 0.170 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 660 | 0.170 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2021 | 39 | 0.170 |
Why?
|
| Cadherins | 1 | 2022 | 181 | 0.170 |
Why?
|
| Transcription Factors | 2 | 2023 | 2452 | 0.170 |
Why?
|
| Myelin P0 Protein | 2 | 2022 | 28 | 0.160 |
Why?
|
| Cytoplasm | 2 | 2018 | 252 | 0.160 |
Why?
|
| Axons | 2 | 2021 | 387 | 0.160 |
Why?
|
| Wings, Animal | 1 | 2020 | 30 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 413 | 0.160 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2021 | 65 | 0.160 |
Why?
|
| Up-Regulation | 1 | 2022 | 833 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 2342 | 0.160 |
Why?
|
| Antibodies | 2 | 2022 | 320 | 0.150 |
Why?
|
| Larva | 3 | 2013 | 249 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2002 | 454 | 0.150 |
Why?
|
| RNA, Messenger | 3 | 2023 | 2565 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 283 | 0.150 |
Why?
|
| Rare Diseases | 1 | 2021 | 207 | 0.150 |
Why?
|
| Interferon Type I | 1 | 2019 | 116 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 463 | 0.140 |
Why?
|
| Inflammation | 2 | 2024 | 1473 | 0.140 |
Why?
|
| Polyphenols | 1 | 2018 | 24 | 0.140 |
Why?
|
| Physical Endurance | 1 | 2018 | 42 | 0.140 |
Why?
|
| Foot | 1 | 2019 | 60 | 0.140 |
Why?
|
| Blotting, Western | 1 | 2020 | 1019 | 0.140 |
Why?
|
| Genes, Dominant | 2 | 2020 | 245 | 0.140 |
Why?
|
| alpha Karyopherins | 1 | 2018 | 8 | 0.140 |
Why?
|
| Sodium Compounds | 1 | 2018 | 9 | 0.140 |
Why?
|
| beta Karyopherins | 1 | 2018 | 16 | 0.140 |
Why?
|
| Arsenites | 1 | 2018 | 18 | 0.140 |
Why?
|
| HLA-DRB1 Chains | 1 | 2018 | 46 | 0.140 |
Why?
|
| ran GTP-Binding Protein | 1 | 2018 | 26 | 0.140 |
Why?
|
| Amyloid | 1 | 2018 | 73 | 0.140 |
Why?
|
| Mitochondria, Muscle | 1 | 2018 | 38 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2021 | 2905 | 0.140 |
Why?
|
| Protein Transport | 3 | 2012 | 363 | 0.130 |
Why?
|
| Cytoplasmic Granules | 1 | 2018 | 51 | 0.130 |
Why?
|
| Proteostasis | 1 | 2018 | 36 | 0.130 |
Why?
|
| Financing, Organized | 1 | 2017 | 21 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2020 | 363 | 0.130 |
Why?
|
| Signal Transduction | 4 | 2026 | 4674 | 0.130 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 141 | 0.130 |
Why?
|
| Antibodies, Antinuclear | 1 | 2017 | 31 | 0.130 |
Why?
|
| Muscle Cells | 1 | 2017 | 25 | 0.130 |
Why?
|
| Huntingtin Protein | 1 | 2017 | 61 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 470 | 0.130 |
Why?
|
| Calpain | 1 | 2017 | 43 | 0.130 |
Why?
|
| Signal Recognition Particle | 1 | 2016 | 11 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 499 | 0.120 |
Why?
|
| HLA Antigens | 1 | 2018 | 225 | 0.120 |
Why?
|
| Dendrites | 1 | 2018 | 183 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 726 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2023 | 896 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 4695 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 567 | 0.120 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 125 | 0.120 |
Why?
|
| Models, Biological | 3 | 2018 | 1390 | 0.120 |
Why?
|
| RNA Interference | 1 | 2018 | 494 | 0.120 |
Why?
|
| Mortality, Premature | 1 | 2016 | 14 | 0.120 |
Why?
|
| Huntington Disease | 1 | 2017 | 122 | 0.120 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2016 | 63 | 0.120 |
Why?
|
| Muscles | 3 | 2023 | 203 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 667 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 410 | 0.120 |
Why?
|
| Protein Aggregates | 1 | 2016 | 38 | 0.120 |
Why?
|
| Edema | 1 | 2016 | 138 | 0.110 |
Why?
|
| Mobility Limitation | 1 | 2015 | 34 | 0.110 |
Why?
|
| Electrophysiology | 2 | 2014 | 250 | 0.110 |
Why?
|
| Disease Progression | 4 | 2023 | 2205 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2015 | 198 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 2106 | 0.110 |
Why?
|
| Synaptotagmin II | 1 | 2014 | 6 | 0.110 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 1 | 2014 | 9 | 0.110 |
Why?
|
| Mitochondria | 1 | 2020 | 763 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 369 | 0.110 |
Why?
|
| Synapses | 1 | 2018 | 446 | 0.110 |
Why?
|
| Exons | 1 | 2017 | 764 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2019 | 3815 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2017 | 403 | 0.100 |
Why?
|
| Genes, Lethal | 1 | 2014 | 72 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2919 | 0.100 |
Why?
|
| Cause of Death | 1 | 2016 | 503 | 0.100 |
Why?
|
| Scoliosis | 1 | 2015 | 157 | 0.100 |
Why?
|
| Hearing Loss | 1 | 2015 | 203 | 0.100 |
Why?
|
| Animal Structures | 1 | 2013 | 9 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2018 | 797 | 0.100 |
Why?
|
| Ion Channels | 1 | 2014 | 198 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2016 | 813 | 0.100 |
Why?
|
| Genetic Therapy | 1 | 2018 | 718 | 0.100 |
Why?
|
| Proteomics | 1 | 2017 | 610 | 0.090 |
Why?
|
| Dipeptides | 2 | 2023 | 62 | 0.090 |
Why?
|
| Dynactin Complex | 1 | 2012 | 5 | 0.090 |
Why?
|
| Photobleaching | 1 | 2012 | 7 | 0.090 |
Why?
|
| Sciatic Neuropathy | 1 | 2012 | 6 | 0.090 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2012 | 9 | 0.090 |
Why?
|
| Age of Onset | 3 | 2020 | 598 | 0.090 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 58 | 0.090 |
Why?
|
| Brain | 4 | 2018 | 3186 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 137 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1710 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 267 | 0.090 |
Why?
|
| Homeostasis | 1 | 2015 | 715 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 315 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2017 | 559 | 0.090 |
Why?
|
| Membrane Potentials | 1 | 2012 | 293 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2022 | 2408 | 0.080 |
Why?
|
| Amino Acid Motifs | 2 | 2020 | 193 | 0.080 |
Why?
|
| Sleep | 1 | 2014 | 370 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1889 | 0.080 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 837 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 3033 | 0.080 |
Why?
|
| Atrophy | 2 | 2023 | 244 | 0.080 |
Why?
|
| Neoplasms | 2 | 2022 | 2944 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2020 | 6423 | 0.080 |
Why?
|
| Drug Design | 1 | 2010 | 161 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2023 | 1627 | 0.070 |
Why?
|
| Protein Binding | 1 | 2012 | 1666 | 0.070 |
Why?
|
| Adolescent | 7 | 2021 | 20754 | 0.070 |
Why?
|
| Actin Cytoskeleton | 2 | 2021 | 50 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3425 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2022 | 17614 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2013 | 451 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 1607 | 0.060 |
Why?
|
| Cell Line | 2 | 2021 | 2579 | 0.060 |
Why?
|
| Child, Preschool | 5 | 2020 | 14985 | 0.060 |
Why?
|
| T-Box Domain Proteins | 1 | 2026 | 120 | 0.060 |
Why?
|
| Prevalence | 2 | 2022 | 2685 | 0.060 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2025 | 28 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2025 | 210 | 0.050 |
Why?
|
| Pedigree | 2 | 2021 | 1683 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2025 | 204 | 0.050 |
Why?
|
| Hydroxylamines | 1 | 2023 | 7 | 0.050 |
Why?
|
| Time Factors | 3 | 2020 | 6190 | 0.050 |
Why?
|
| Connexins | 1 | 2023 | 64 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2024 | 339 | 0.050 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2023 | 16 | 0.050 |
Why?
|
| RNA Recognition Motif Proteins | 1 | 2023 | 19 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 1838 | 0.050 |
Why?
|
| Child | 6 | 2020 | 26165 | 0.050 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2023 | 28 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2023 | 84 | 0.050 |
Why?
|
| Complement System Proteins | 1 | 2023 | 59 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2023 | 110 | 0.050 |
Why?
|
| Sp4 Transcription Factor | 1 | 2022 | 4 | 0.050 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2022 | 6 | 0.050 |
Why?
|
| Diffusion | 1 | 2002 | 58 | 0.050 |
Why?
|
| Clathrin | 1 | 2002 | 23 | 0.050 |
Why?
|
| Synaptic Membranes | 1 | 2002 | 23 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2022 | 46 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2022 | 45 | 0.050 |
Why?
|
| Smad Proteins | 1 | 2002 | 44 | 0.050 |
Why?
|
| Dystrophin | 1 | 2022 | 40 | 0.050 |
Why?
|
| Interferons | 1 | 2023 | 136 | 0.050 |
Why?
|
| Myoblasts | 1 | 2022 | 34 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 790 | 0.050 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2021 | 25 | 0.040 |
Why?
|
| Biological Transport | 1 | 2002 | 332 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2023 | 234 | 0.040 |
Why?
|
| Muscle Development | 1 | 2022 | 73 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 361 | 0.040 |
Why?
|
| Nervous System | 1 | 2002 | 119 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2021 | 11 | 0.040 |
Why?
|
| Genotype | 2 | 2019 | 2605 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 441 | 0.040 |
Why?
|
| Wheelchairs | 1 | 2020 | 18 | 0.040 |
Why?
|
| Walk Test | 1 | 2021 | 28 | 0.040 |
Why?
|
| Walking | 1 | 2023 | 213 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2022 | 204 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2023 | 412 | 0.040 |
Why?
|
| Time | 1 | 2021 | 92 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2022 | 180 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2021 | 176 | 0.040 |
Why?
|
| COS Cells | 1 | 2021 | 255 | 0.040 |
Why?
|
| Orthotic Devices | 1 | 2020 | 20 | 0.040 |
Why?
|
| Early Growth Response Transcription Factors | 1 | 2020 | 2 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2020 | 28 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2020 | 14 | 0.040 |
Why?
|
| Mucoproteins | 1 | 2020 | 11 | 0.040 |
Why?
|
| Protein Stability | 1 | 2021 | 165 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2002 | 201 | 0.040 |
Why?
|
| Apolipoproteins A | 1 | 2020 | 52 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2022 | 233 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2002 | 295 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 233 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2002 | 655 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 161 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2021 | 170 | 0.040 |
Why?
|
| Arginine | 1 | 2022 | 336 | 0.040 |
Why?
|
| Genes, Recessive | 1 | 2020 | 199 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2024 | 714 | 0.040 |
Why?
|
| Heterozygote | 1 | 2022 | 720 | 0.040 |
Why?
|
| Synaptic Vesicles | 2 | 2014 | 68 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2021 | 114 | 0.040 |
Why?
|
| United States | 3 | 2023 | 11827 | 0.040 |
Why?
|
| Prognosis | 2 | 2020 | 4894 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 454 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2020 | 201 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 694 | 0.040 |
Why?
|
| Histones | 1 | 2023 | 545 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 225 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 277 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1452 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 279 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2020 | 597 | 0.040 |
Why?
|
| Sarcomeres | 1 | 2018 | 33 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2023 | 931 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 59 | 0.040 |
Why?
|
| Myelin Proteins | 1 | 2019 | 78 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2019 | 41 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 373 | 0.040 |
Why?
|
| Biological Availability | 1 | 2018 | 138 | 0.040 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 39 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 490 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 622 | 0.030 |
Why?
|
| Protein Folding | 1 | 2018 | 215 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 382 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 451 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 809 | 0.030 |
Why?
|
| DNA Damage | 1 | 2021 | 513 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2024 | 3388 | 0.030 |
Why?
|
| Chromatin | 1 | 2021 | 502 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3507 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 1458 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 64 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 823 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2002 | 1006 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 293 | 0.030 |
Why?
|
| Thigh | 1 | 2016 | 50 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 384 | 0.030 |
Why?
|
| Machine Learning | 1 | 2020 | 385 | 0.030 |
Why?
|
| Necrosis | 1 | 2016 | 194 | 0.030 |
Why?
|
| Research Personnel | 1 | 2017 | 141 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 1391 | 0.030 |
Why?
|
| Aftercare | 1 | 2017 | 150 | 0.030 |
Why?
|
| G-Quadruplexes | 1 | 2015 | 11 | 0.030 |
Why?
|
| Australia | 1 | 2016 | 171 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2015 | 83 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 783 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2015 | 69 | 0.030 |
Why?
|
| Computational Biology | 1 | 2020 | 868 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2835 | 0.030 |
Why?
|
| Risk Factors | 2 | 2022 | 10942 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 914 | 0.030 |
Why?
|
| Europe | 1 | 2016 | 366 | 0.030 |
Why?
|
| Adiposity | 1 | 2016 | 208 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 72 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1493 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 443 | 0.030 |
Why?
|
| Health Surveys | 1 | 2016 | 255 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 729 | 0.030 |
Why?
|
| Registries | 1 | 2022 | 1605 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1723 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2002 | 1602 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1925 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1153 | 0.030 |
Why?
|
| Exocytosis | 1 | 2014 | 66 | 0.030 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 12 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 1215 | 0.030 |
Why?
|
| Hormone Antagonists | 1 | 2014 | 43 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Mifepristone | 1 | 2014 | 85 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 575 | 0.030 |
Why?
|
| ARNTL Transcription Factors | 1 | 2014 | 46 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 145 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1377 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 209 | 0.030 |
Why?
|
| Reaction Time | 1 | 2014 | 156 | 0.020 |
Why?
|
| Vinculin | 1 | 2013 | 7 | 0.020 |
Why?
|
| Talin | 1 | 2013 | 11 | 0.020 |
Why?
|
| Cell-Matrix Junctions | 1 | 2013 | 9 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2013 | 35 | 0.020 |
Why?
|
| Vibration | 1 | 2013 | 30 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 61 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3397 | 0.020 |
Why?
|
| Hearing Disorders | 1 | 2013 | 42 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 89 | 0.020 |
Why?
|
| Integrins | 1 | 2013 | 90 | 0.020 |
Why?
|
| Genome, Insect | 1 | 2013 | 80 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2013 | 76 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 1685 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 623 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 197 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2018 | 722 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 3715 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 2298 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2355 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 750 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 1149 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 2847 | 0.020 |
Why?
|
| Physicians | 1 | 2016 | 634 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3803 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 13269 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 12860 | 0.010 |
Why?
|
| Cell Size | 1 | 2002 | 80 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 310 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 139 | 0.010 |
Why?
|